Bone and Bones
Liver Transplantation
Transplantation, Homologous
Bone Marrow Transplantation
Bone Remodeling
Hematopoietic Stem Cell Transplantation
Transplantation, Autologous
Lung Transplantation
Bone Density
Stem Cell Transplantation
Transplantation Conditioning
Graft Survival
Organ Transplantation
Bone Marrow
Bone Marrow Cells
Graft Rejection
Tissue Donors
Islets of Langerhans Transplantation
Transplantation
Transplantation Immunology
Cell Transplantation
Transplantation Chimera
Bone Development
Graft vs Host Disease
Immunosuppressive Agents
Transplantation, Isogeneic
Treatment Outcome
Transplantation, Heterotopic
Cord Blood Stem Cell Transplantation
Bone Regeneration
Heart-Lung Transplantation
Tissue and Organ Procurement
Transplantation Tolerance
Retrospective Studies
Bone Matrix
Peripheral Blood Stem Cell Transplantation
Immunosuppression
Histocompatibility Testing
Liver Failure
Fetal Tissue Transplantation
Postoperative Complications
Skin Transplantation
Mesenchymal Stem Cell Transplantation
Whole-Body Irradiation
Support of the anterior column with allografts in tuberculosis of the spine. (1/1358)
Fresh-frozen allografts from the humerus were used to help to stabilise the spine after anterior decompression for tuberculosis in 47 children with a mean age of 4.2 years (2 to 9). The average angle of the gibbus, before operation, was 53 degrees; at follow-up, two years later, it was 15 degrees. Rejection of the graft or deep sepsis was not seen. Cross trabeculation between the allograft and the vertebral body was observed at six months, with remodelling occurring at approximately 30 months. (+info)Mechanical considerations in impaction bone grafting. (2/1358)
In impaction grafting of contained bone defects after revision joint arthroplasty the graft behaves as a friable aggregate and its resistance to complex forces depends on grading, normal load and compaction. Bone mills in current use produce a distribution of particle sizes more uniform than is desirable for maximising resistance to shear stresses. We have performed experiments in vitro using morsellised allograft bone from the femoral head which have shown that its mechanical properties improve with increasing normal load and with increasing shear strains (strain hardening). The mechanical strength also increases with increasing compaction energy, and with the addition of bioglass particles to make good the deficiency in small and very small fragments. Donor femoral heads may be milled while frozen without affecting the profile of the particle size. Osteoporotic femoral heads provide a similar grading of sizes, although fewer particles are obtained from each specimen. Our findings have implications for current practice and for the future development of materials and techniques. (+info)Evaluation of the allograft-prosthesis composite technique for proximal femoral reconstruction after resection of a primary bone tumour. (3/1358)
OBJECTIVE: To evaluate clinical and functional outcomes resulting from the allograft-composite technique used for proximal femoral osteoarticular reconstruction in patients who had limb salvage surgery for primary bone tumours. DESIGN: A retrospective review of a prospectively gathered database to provide a descriptive study. SETTING: A tertiary care musculoskeletal oncology unit in a university hospital. PATIENTS AND INTERVENTIONS: Patients treated between 1987 and 1993 were eligible for inclusion in this study if they met the following criteria: they were treated surgically for a primary malignant bone tumour; and a proximal femoral allograft-implant composite technique was used for the reconstruction. MAIN OUTCOME MEASURES: Major postoperative complications with emphasis on mechanical complications in the reconstructive composite implant. Functional outcome in a subset of patients using the 1987 and 1994 versions of the Musculoskeletal Tumor Society instrument, the Short-Form-36 and the Toronto Extremity Salvage Score. RESULTS: There were 5 mechanical and 2 infectious complications requiring surgical intervention. Functional scores were generally low. CONCLUSIONS: Our results suggest that the perceived benefits of the composite technique may accrue only to a few patients, partly owing to the risk of mechanical complications. Although these can be reduced by avoiding the use of cement in the host femur, the generally poor functional outcomes suggest that this technique needs to be studied further in this group of patients and compared with other reconstructive techniques, particularly the prosthetic implant. (+info)Bone-peg grafting for osteochondritis dissecans of the elbow. (4/1358)
In the treatment of osteochondritis dissecans involving the elbow, we have used a bone-peg graft taken from the proximal part of the ulna and inserted into the defect. Thirty-two patients were followed from 2 to 10.5 years. The graft was utilised in 20 elbows, and 6 of these also had concomitant removal of a loose body. Another 6 elbows had removal of a loose body only. Ten elbows were treated conservatively in 5 of these the outcome was unsatisfactory, including 4 in which a bone-peg graft was later necessary. The bone-peg graft gave the best short-term results. Bony union of the dissecans site and reconstitution of subchondral bone required an average of 6.5 months. In 15 patients followed for a minimum of 5 years, the bone-peg graft was effective in limiting the development of osteoarthritis. Bone-peg grafting is a reliable method for treating osteochondritis dissecans of the elbow. (+info)Salvage of the head of the radius after fracture-dislocation of the elbow. A case report. (5/1358)
We describe a patient with a Mason type-III fracture of the head of the radius associated with traumatic dislocation of the elbow. The radial head was intact throughout its circumference despite being completely detached from the shaft and devoid of any soft-tissue attachments. Severe comminution of the radial neck prevented reconstruction by internal fixation and precluded prosthetic replacement of the head. The head was fixed to the shaft with a tricortical iliac-crest bone graft which replaced the neck. Two years later, the patient had a stable elbow with flexion from 10 degrees to 130 degrees. Radiologically, the head of the radius appeared to be viable and the bone graft had incorporated. (+info)The pathology of bone allograft. (6/1358)
We analysed the histological findings in 1146 osteoarthritic femoral heads which would have been considered suitable for bone-bank donation to determine whether pathological lesions, other than osteoarthritis, were present. We found that 91 femoral heads (8%) showed evidence of disease. The most common conditions noted were chondrocalcinosis (63 cases), avascular necrosis (13), osteomas (6) and malignant tumours (one case of low-grade chondrosarcoma and two of well-differentiated lymphocytic lymphoma). There were two with metabolic bone disease (Paget's disease and hyperparathyroid bone disease) and four with inflammatory (rheumatoid-like) arthritis. Our findings indicate that occult pathological conditions are common and it is recommended that histological examination of this regularly used source of bone allograft should be included as part of the screening protocol for bone-bank collection. (+info)Histopathology of retrieved allografts of the femoral head. (7/1358)
From November 1994 to March 1997, we harvested 137 grafts of the femoral head from 125 patients for donation during total hip arthroplasty according to the guidelines of the American Associations of Tissue Banks (AATB) and the European Association of Musculo-Skeletal transplantation (EAMST). In addition to the standards recommended by these authorities, we performed histopathological examination of a core biopsy of the retrieved bone allograft and of the synovium. Of the 137 allografts, 48 (35.0%) fulfilled all criteria and were free for donation; 31 (22.6%) were not regarded as suitable for transplantation because the serological retests at six months were not yet complete and 58 (42.3%) were discarded because of incomplete data. Of those discarded, five showed abnormal histopathological findings; three were highly suspicious of low-grade B-cell lymphoma, one of monoclonal plasmacytosis and the other of non-specific inflammation of bone marrow. However, according to the standards of the AATB or EAMST they all met the criteria and were eligible for transplantation. Our findings indicate that the incidence of abnormal histopathology in these retrieved allografts was 3.6%. Since it is essential to confirm the quality of donor bones in bone banking, we advise that histopathological screening of donor bone should be performed to exclude abnormal allografts. (+info)Multi-bracket appliance in management of mandibular reconstruction with vascularized bone graft. (8/1358)
BACKGROUND: The most commonly used tool for maxillo-mandibular fixation to the patient who underwent reconstruction using a vascularized bone graft after mandibular resection is a dental arch-bar. However, the occlusal relationship achieved by this method is not ideal. Different from the dental arch-bar, the multi-bracket appliance which is frequently used in orthodontic treatment can control the position of each individual tooth three dimensionally. Thus, this appliance was applied for maxillo-mandibular fixation to patients who underwent mandibular reconstruction using a vascularized bone graft. METHODS: A multi-bracket appliance was applied to three patients. Prior to the surgery, standard edgewise brackets were bonded to the teeth in the maxilla and in the remaining mandible. After mandibular resection, wires for maxillo-mandibular fixation were applied. The harvested bone was then carefully fixed with miniplates to maintain the occlusion. The multi-bracket appliance was worn for 3 months when the wound contraction became mild. RESULTS: All three cases demonstrated stable and good occlusion. They also demonstrated satisfactory post-surgical facial appearance. CONCLUSIONS: Compared to conventional dental arch-bars, a multi-bracket appliance offers improved management of mandibular reconstruction. Firstly, its properties are helpful in maintaining occlusion of the remaining dentition accurately in bone grafting procedure as well as protecting against postsurgical wound contraction. Secondly, the multi-bracket appliance keeps the oral cavity clean without periodontal injury. As a result, stable occlusion of the residual teeth and good facial appearance were obtained. (+info)There are several factors that can contribute to bone resorption, including:
1. Hormonal changes: Hormones such as parathyroid hormone (PTH) and calcitonin can regulate bone resorption. Imbalances in these hormones can lead to excessive bone resorption.
2. Aging: As we age, our bones undergo remodeling more frequently, leading to increased bone resorption.
3. Nutrient deficiencies: Deficiencies in calcium, vitamin D, and other nutrients can impair bone health and lead to excessive bone resorption.
4. Inflammation: Chronic inflammation can increase bone resorption, leading to bone loss and weakening.
5. Genetics: Some genetic disorders can affect bone metabolism and lead to abnormal bone resorption.
6. Medications: Certain medications, such as glucocorticoids and anticonvulsants, can increase bone resorption.
7. Diseases: Conditions such as osteoporosis, Paget's disease of bone, and bone cancer can lead to abnormal bone resorption.
Bone resorption can be diagnosed through a range of tests, including:
1. Bone mineral density (BMD) testing: This test measures the density of bone in specific areas of the body. Low BMD can indicate bone loss and excessive bone resorption.
2. X-rays and imaging studies: These tests can help identify abnormal bone growth or other signs of bone resorption.
3. Blood tests: Blood tests can measure levels of certain hormones and nutrients that are involved in bone metabolism.
4. Bone biopsy: A bone biopsy can provide a direct view of the bone tissue and help diagnose conditions such as Paget's disease or bone cancer.
Treatment for bone resorption depends on the underlying cause and may include:
1. Medications: Bisphosphonates, hormone therapy, and other medications can help slow or stop bone resorption.
2. Diet and exercise: A healthy diet rich in calcium and vitamin D, along with regular exercise, can help maintain strong bones.
3. Physical therapy: In some cases, physical therapy may be recommended to improve bone strength and mobility.
4. Surgery: In severe cases of bone resorption, surgery may be necessary to repair or replace damaged bone tissue.
Some common types of bone neoplasms include:
* Osteochondromas: These are benign tumors that grow on the surface of a bone.
* Giant cell tumors: These are benign tumors that can occur in any bone of the body.
* Chondromyxoid fibromas: These are rare, benign tumors that develop in the cartilage of a bone.
* Ewing's sarcoma: This is a malignant tumor that usually occurs in the long bones of the arms and legs.
* Multiple myeloma: This is a type of cancer that affects the plasma cells in the bone marrow.
Symptoms of bone neoplasms can include pain, swelling, or deformity of the affected bone, as well as weakness or fatigue. Treatment options depend on the type and location of the tumor, as well as the severity of the symptoms. Treatment may involve surgery, radiation therapy, chemotherapy, or a combination of these.
Some common types of bone diseases include:
1. Osteoporosis: A condition characterized by brittle, porous bones that are prone to fracture.
2. Osteoarthritis: A degenerative joint disease that causes pain and stiffness in the joints.
3. Rheumatoid arthritis: An autoimmune disorder that causes inflammation and pain in the joints.
4. Bone cancer: A malignant tumor that develops in the bones.
5. Paget's disease of bone: A condition characterized by abnormal bone growth and deformity.
6. Osteogenesis imperfecta: A genetic disorder that affects the formation of bone and can cause brittle bones and other skeletal deformities.
7. Fibrous dysplasia: A rare condition characterized by abnormal growth and development of bone tissue.
8. Multiple myeloma: A type of cancer that affects the plasma cells in the bone marrow.
9. Bone cysts: Fluid-filled cavities that can form in the bones and cause pain, weakness, and deformity.
10. Bone spurs: Abnormal growths of bone that can form along the edges of joints and cause pain and stiffness.
Bone diseases can be diagnosed through a variety of tests, including X-rays, CT scans, MRI scans, and bone biopsies. Treatment options vary depending on the specific disease and can include medication, surgery, or a combination of both.
The diagnosis of GVHD is based on a combination of clinical findings, laboratory tests, and biopsies. Treatment options include immunosuppressive drugs, corticosteroids, and in severe cases, stem cell transplantation reversal or donor lymphocyte infusion.
Prevention of GVHD includes selecting the right donor, using conditioning regimens that minimize damage to the recipient's bone marrow, and providing appropriate immunosuppression after transplantation. Early detection and management of GVHD are critical to prevent long-term complications and improve survival rates.
There are several causes of liver failure, including:
1. Alcohol-related liver disease: Prolonged and excessive alcohol consumption can damage liver cells, leading to inflammation, scarring, and eventually liver failure.
2. Viral hepatitis: Hepatitis A, B, and C are viral infections that can cause inflammation and damage to the liver, leading to liver failure.
3. Non-alcoholic fatty liver disease (NAFLD): A condition where there is an accumulation of fat in the liver, leading to inflammation and scarring.
4. Drug-induced liver injury: Certain medications can cause liver damage and failure, especially when taken in high doses or for extended periods.
5. Genetic disorders: Certain inherited conditions, such as hemochromatosis and Wilson's disease, can cause liver damage and failure.
6. Acute liver failure: This is a sudden and severe loss of liver function, often caused by medication overdose or other toxins.
7. Chronic liver failure: A gradual decline in liver function over time, often caused by cirrhosis or NAFLD.
Symptoms of liver failure can include:
1. Jaundice (yellowing of the skin and eyes)
2. Fatigue
3. Loss of appetite
4. Nausea and vomiting
5. Abdominal pain
6. Confusion and altered mental state
7. Easy bruising and bleeding
Diagnosis of liver failure is typically made through a combination of physical examination, medical history, and laboratory tests, such as blood tests to check for liver enzymes and bilirubin levels. Imaging tests, such as ultrasound and CT scans, may also be used to evaluate the liver.
Treatment of liver failure depends on the underlying cause and severity of the condition. In some cases, a liver transplant may be necessary. Other treatments may include medications to manage symptoms, such as nausea and pain, and supportive care to maintain nutrition and hydration. In severe cases, hospitalization may be required to monitor and treat complications.
Prevention of liver failure is important, and this can be achieved by:
1. Avoiding alcohol or drinking in moderation
2. Maintaining a healthy weight and diet
3. Managing underlying medical conditions, such as diabetes and high blood pressure
4. Avoiding exposure to toxins, such as certain medications and environmental chemicals
5. Getting vaccinated against hepatitis A and B
6. Practicing safe sex to prevent the spread of hepatitis B and C.
1. Infection: Bacterial or viral infections can develop after surgery, potentially leading to sepsis or organ failure.
2. Adhesions: Scar tissue can form during the healing process, which can cause bowel obstruction, chronic pain, or other complications.
3. Wound complications: Incisional hernias, wound dehiscence (separation of the wound edges), and wound infections can occur.
4. Respiratory problems: Pneumonia, respiratory failure, and atelectasis (collapsed lung) can develop after surgery, particularly in older adults or those with pre-existing respiratory conditions.
5. Cardiovascular complications: Myocardial infarction (heart attack), cardiac arrhythmias, and cardiac failure can occur after surgery, especially in high-risk patients.
6. Renal (kidney) problems: Acute kidney injury or chronic kidney disease can develop postoperatively, particularly in patients with pre-existing renal impairment.
7. Neurological complications: Stroke, seizures, and neuropraxia (nerve damage) can occur after surgery, especially in patients with pre-existing neurological conditions.
8. Pulmonary embolism: Blood clots can form in the legs or lungs after surgery, potentially causing pulmonary embolism.
9. Anesthesia-related complications: Respiratory and cardiac complications can occur during anesthesia, including respiratory and cardiac arrest.
10. delayed healing: Wound healing may be delayed or impaired after surgery, particularly in patients with pre-existing medical conditions.
It is important for patients to be aware of these potential complications and to discuss any concerns with their surgeon and healthcare team before undergoing surgery.
Recurrence can also refer to the re-emergence of symptoms in a previously treated condition, such as a chronic pain condition that returns after a period of remission.
In medical research, recurrence is often studied to understand the underlying causes of disease progression and to develop new treatments and interventions to prevent or delay its return.
* Osteogenesis imperfecta (OI): A genetic disorder that affects the formation of bone tissue, leading to fragile bones and an increased risk of fractures.
* Rickets: A vitamin D-deficient disease that causes softening of the bones in children.
* Osteomalacia: A condition similar to rickets, but affecting adults and caused by a deficiency of vitamin D or calcium.
* Hyperparathyroidism: A condition in which the parathyroid glands produce too much parathyroid hormone (PTH), leading to an imbalance in bone metabolism and an increase in bone resorption.
* Hypoparathyroidism: A condition in which the parathyroid glands produce too little PTH, leading to low levels of calcium and vitamin D and an increased risk of osteoporosis.
Bone diseases, metabolic are typically diagnosed through a combination of physical examination, imaging studies such as X-rays or CT scans, and laboratory tests to evaluate bone metabolism. Treatment depends on the specific underlying cause of the disease and may include medications, dietary changes, or surgery.
Bone Marrow Transplantation (journal)
Peripheral stem cell transplantation
Hematopoietic stem cell transplantation
Gianotti-Crosti syndrome
Reticular dysgenesis
Type 1 regulatory T cell
Diamond-Blackfan anemia
Primary immunodeficiency
Hematopoietic stem cell
Granulocyte colony-stimulating factor
List of Nobel laureates affiliated with Columbia University as alumni or faculty
Stem cell marker
Cyclophosphamide
Andrew Pecora
Adrenoleukodystrophy
Carmustine
Daratumumab
CAR T cell
Gift of Life Marrow Registry
Namazi Hospital
Lysosomal acid lipase deficiency
FLAG (chemotherapy)
Phialophora verrucosa
Linezolid
Caphosol
Scientific consensus
CLEC11A
FMS-like tyrosine kinase 3 ligand
Muromonab-CD3
Nabil F. Saba
National Medical Research Centre for Hematology
List of alumni of Magdalen College, Oxford
Taipei Veterans General Hospital
Andrew Wakefield
CD34
October 1964
Ancestim
Lipid storage disorder
Angelina Jolie
Nintendo thumb
Armen Margarian
Singapore Cord Blood Bank
Mayo Hospital
Bioluminescence
Voriconazole
Waldenström macroglobulinemia
Human T-lymphotropic virus 1
Gemtuzumab ozogamicin
List of University of Sydney people
Organ donation in India
Immunosenescence
Primary effusion lymphoma
INSL3
Hypogammaglobulinemia
Hand transplantation
Pearson syndrome
Areca nut
Bone Marrow Transplantation | Bone Marrow Transplant | MedlinePlus
'Father of bone marrow transplantation,' Dr. E. Donnall Thomas, dies | NHLBI,...
Epidemiologic Notes and Reports
Transmission of HIV Through Bone Transplantation:
Case Report and Public Health...
NIH Guide: MECHANISMS OF POST BONE MARROW TRANSPLANTATION LUNG INJURY
Bone Marrow Transplantation, Hemoglobinopathies, SCALLOP - Full Text View - ClinicalTrials.gov
NIH VideoCast - TRACO: Leukemias, Bone Marrow Transplantation
Liver disease after bone marrow transplantation - PubMed
Pulmonary function after bone marrow transplantation for chronic myeloid leukaemia. | Thorax
Umbilical cord blood stem cell transplantation from unrelated HLA-matched donor in an infant with severe congenital neutropenia...
New Patients' bone marrow transplantation guide | José Carreras Leukaemia Foundation
Combination Chemotherapy, Biological Therapy, and Bone Marrow Transplantation in Treating Patients With Acute Myeloid Leukemia ...
Fluconazole vs low-dose amphotericin B for the prevention of fungal infections in patients undergoing bone marrow...
Allogeneic bone marrow transplantation for STAT3 deficiency | NIH Research Festival
Ex vivo spermine dialdehyde treatment prevents lethal GVHD in a murine bone marrow transplantation model. | Scholars@Duke
Allogeneic bone marrow transplantation for Alexander's disease<...
Bone Marrow Collection For Transplantation Top Open Access Journals | Peer Reviewed Journals
bone marrow transplantation
EN (en)
Thalassemia Intermedia Treatment & Management: Approach Considerations, Clinical Management, Surgical Intervention
Nodular regenerative hyperplasia of the liver following bone marrow transplantation - Fingerprint
- Experts@Minnesota
Repairing A Damaged Heart With Stem Cells may Relegate the Need for Transplantation Surgeries
Free Bone Marrow Transplantation (Vademecum) 1996
Covid-19 containment measures adopted in bone marrow transplantation service. | Rev Bras Enferm;73 Suppl 2: e20200476, 2020. ...
Occupational life of patients surviving a bone marrow transplantation: Exploratory study
Collaborations Reporting System - The NIH Bone Marrow Stromal Cell Transplantation Center
Subjects: Bone Transplantation - Digital Collections - National Library of Medicine Search Results
Alendronate, Calcitriol Similar in Reducing Bone Loss After Heart Transplantation | NIAMS Archives
Transplantation and Donation: MedlinePlus
LEUKINE
(sargramostim)
Allogeneic9
- Histopathological changes in the liver after allogeneic bone marrow transplantation. (nih.gov)
- Patients with STAT3 deficiency are infrequently offered allogeneic bone marrow transplantation (alloBMT), as many are managed with supportive care and antibiotic prophylaxis alone. (nih.gov)
- Spermine dialdehyde (SDA), an oxidized product of spermine which irreversibly suppresses T cell and NK cell activities, was evaluated as an ex vivo purging agent in the prevention of graft-versus-host disease (GVHD) in mice transplanted with SDA-treated allogeneic bone marrow. (duke.edu)
- SDA may have clinical application as a purging agent in allogeneic bone marrow transplantation. (duke.edu)
- In this case report, we evaluate the efficacy of allogeneic bone marrow transplantation (BMT) in a 7-month-old female with the infantile form of Alexander's disease. (northwestern.edu)
- Increasing age has been historically implicated in higher mortality after high-dose allogeneic HCT for patients with hematologic malignancies [cancers of the blood or bone marrow]. (baretnews.com)
- To address this limitation, a nonmyeloablative (an approach using lower doses of chemotherapy and/or radiation that does not lead to eradication of all bone marrow cells prior to stem cell transplant) conditioning regimen for allogeneic HCT was developed. (baretnews.com)
- Many studies of allogeneic marrow transplantation have shown that a higher dose of marrow cells correlates with a stronger hematopoietic engraftment and lower mortality from infectious complications. (nih.gov)
- Treatment for patients with thalassemia major includes long-term transfusion therapy, iron chelation, splenectomy, allogeneic hematopoietic stem cell transplantation, gene therapy, and supportive measures. (medscape.com)
Hematopoietic5
- Read more about the lasting impact of Dr. Thomas' work in a 1997 New England Journal of Medicine article, Hematopoietic-Cell Transplantation at 50 . (nih.gov)
- Most hematopoietic stem cells are found in the bone marrow, but some cells, called peripheral blood stem cells (PBSCs), are found in the bloodstream. (longdom.org)
- To address this challenge, researchers have been trying to develop reliable, lab-based methods for making the vital, blood-producing component of bone marrow: hematopoietic stem cells (HSCs). (nih.gov)
- To describe the experience of nursing , in adopting containment measures , in the care of patients undergoing hematopoietic stem cell transplantation to avoid COVID-19. (bvsalud.org)
- In vitro exposure of human bone marrow cells to LEUKINE at concentrations ranging from 1-100 ng/mL results in the proliferation of hematopoietic progenitors and in the formation of pure granulocyte, pure macrophage and mixed granulocytemacrophage colonies. (nih.gov)
Patients20
- We would like to treat patients using bone marrow transplantation, a treatment that has been used for people with SCD. (clinicaltrials.gov)
- Currently, very little has been reported about organ function after bone marrow transplants in patients with sickle cell anemia. (clinicaltrials.gov)
- We have studied liver status before and after bone marrow transplantation in 43 consecutive patients and have related this to survival and factors that are recognised to cause liver injury. (nih.gov)
- Minor abnormalities of liver tests occurred in 21% of patients before grafting but this did not influence survival or the development of liver disease after transplantation. (nih.gov)
- Stem cell transplantation in patients with severe congenital neutropenia without evidence of leukemic transformation. (nature.com)
- Compare 4 vs 5 courses of total treatment, with either chemotherapy or bone marrow transplantation (BMT) as the final course, with respect to remission duration, relapse rate, disease free mortality, and overall survival in these patients. (clinicaltrials.gov)
- All patients received reduced-intensity conditioning, a T-cell-replete bone marrow graft (1 HLA-haploidentical, 2 HLA-matched related), and post-transplant cyclophosphamide-based graft-versus-host disease (GVHD) prophylaxis. (nih.gov)
- In a study of 30 bone-marrow transplant patients suffering from bloodstream infections, researchers used a newly developed computational tool called StrainSifter to match microbial DNA from close to one-third of the infections to bugs already living in the patients' large intestines [1]. (nih.gov)
- Bone marrow transplants offer a way to cure leukemia, sickle cell disease, and a variety of other life-threatening blood disorders.There are two major problems, however: One is many patients don't have a well-matched donor to provide the marrow needed to reconstitute their blood with healthy cells. (nih.gov)
- and also the local measures implemented in the health service , such as the reduction in the number of hospitalizations for transplantation , clinical screening of outpatients entering the service, monitoring of respiratory signs and symptoms , the allocation of specific isolation rooms for those suspected of the disease and testing of symptomatic patients . (bvsalud.org)
- The results point to the value of treating bone loss in transplant patients. (nih.gov)
- Elizabeth Shane, M.D., of the Columbia University College of Physicians and Surgeons in New York, and her colleagues there and at the Newark-Beth Israel Medical Center in New Jersey conducted a randomized trial involving 149 patients in whom either alendronate or calcitriol was begun within the first few weeks after heart transplantation. (nih.gov)
- The results were compared with those from a reference group of 27 patients who had undergone transplantation during the same time period. (nih.gov)
- The bottom line," says Joan McGowan, Ph.D., chief of the NIAMS Musculoskeletal Diseases Branch, "is that drugs to prevent bone loss should be considered in all transplant patients. (nih.gov)
- receipt of bone marrow or stem cells transplant) had survival and progression-free survival outcomes suggesting that this treatment approach may be a viable option for older patients with these malignancies, according to a scientific study. (baretnews.com)
- Prior to their participation in this study, patients will undergo the following evaluations: a physical exam, blood work, breathing tests, heart-function tests, chest and sinus x-rays, and bone-marrow sampling. (nih.gov)
- To compare survival rates of patients with hematologic cancers that received transplantation of granulocyte colony stimulating factor (G-CSF) mobilized peripheral blood stem cells (PBSC) versus marrow from HLA-compatible unrelated donors. (nih.gov)
- In our case, the patients were treated with wide resection of the bone segment. (org.al)
- Although we verified the safety of the autologous bone marrow stem cell transplantation in sensorineural hearing loss patients but we could not achieve significant improvement in hearing. (ejao.org)
- From these research results, we tried transplantation of MSCs in patients with sensorineural hearing loss. (ejao.org)
Leukemia4
- The NHLBI joins the rest of the scientific community in mourning the loss of a true pioneer, E. Donnall Thomas, M.D. Dr. Thomas, a hematologist who earned a Nobel Prize in 1990 for establishing bone marrow transplantation as a successful treatment for leukemia and other blood conditions, died Oct. 20 at the age of 92. (nih.gov)
- Animation and slides providing graphic explanation of Bone Marrow Transplantation (BMT)/Stem Cell Transplantation that is done for leukemia and other blood-related disorders. (medindia.net)
- Eligible subjects were less than 66 years of age and were planning to undergo transplantation for acute leukemia, myelodysplasia, chronic myeloid or myelomonocytic leukemia, or myelofibrosis. (nih.gov)
- Sargramostim is a colony stimulating factor that is FDA approved for the treatment of granulocytopenia following induction chemotherapy in acute myelogenous leukemia , mobilization and following transplantation of autologous peripheral blood progentior cells, myeloid reconstitution after autologous bone marrow transplantation, myeloid reconstitution after allogeneic bone marrow transplantation and bone marrow transplantation failure or engraftment delay. (wikidoc.org)
Donor5
- Dr. Thomas recognized the importance of matching donors to recipients, helped determine the best way to suppress the immune system before transplantation, exploited the graft-versus-tumor effect whereby donor cells recognize and help eliminate cancer, and reduced severe reactions known as graft-versus-host disease by using the drug methotrexate-thus showing that bone marrow transplantation could be a viable treatment option for certain life-threatening diseases. (nih.gov)
- The recipient had no known risk for HIV infection other than the bone grafting procedure, and the bone donor was subsequently found to have been infected with HIV. (cdc.gov)
- The bone donor was a 52-year-old man who had donated his left femoral head, which was excised during a hip arthroplasty procedure performed for degenerative joint disease in November 1984. (cdc.gov)
- We report here a 6-month-old boy with severe congenital neutropenia (SCN) successfully treated by cord blood stem cell transplantation (CBSCT) from an unrelated donor. (nature.com)
- A much more powerful option would be to develop a means for every patient to serve as their own bone marrow donor. (nih.gov)
Thinking bone marrow1
- Are you still thinking bone marrow and spinal cord are the same? (fcarreras.org)
Mesenchymal stem1
- Recently, many studies revealed that mesenchymal stem cells from umbilical cord blood (UCB) or Bone marrow (BM) can differentiate into multiple lineage cells. (ejao.org)
Transplants1
- Today, bone marrow and blood stem cell transplants are performed to treat or cure blood cancers and certain immune conditions and blood diseases. (nih.gov)
Myeloid2
- Pulmonary function after bone marrow transplantation for chronic myeloid leukaemia. (bmj.com)
- When a minimum number of bone marrow cells were used for reconstitution, SDA-treated marrow reconstituted lethally irradiated mice as effectively as control marrow suggesting that SDA had little impact on early myeloid cells which are required for engraftment. (duke.edu)
Stem Cell6
- Building on the legacy of Dr. Thomas and others, the NHLBI supports research in bone marrow transplantation and stem cell biology, including through the Blood and Marrow Transplant Clinical Trials Network , with the goal of treating and even curing more diseases through transplantation. (nih.gov)
- The stem cell, now without the disease-causing gene, repopulated her immune system with healthy bone marrow-derived immune cells, resulting in cure of the syndrome. (nih.gov)
- Subjects were randomly assigned in a 1:1 ratio to peripheral-blood stem-cell or bone marrow transplantation, stratified according to transplantation center and disease risk. (nih.gov)
- There was no detected significant survival differences between peripheral-blood stem-cell and bone marrow transplantation from unrelated donors. (nih.gov)
- Stem cell transplantation represents a promising therapy for several degenerating and necrotic diseases. (ejao.org)
- In spite of mesenchymal stem cell (MSC) transplantation has not been tried for hearing loss yet, MSCs have been applied to many other organ disorders like hematological disorders, cardiovascular disease, osteogenesis imperfecta, some neurological pathologies and even cancer. (ejao.org)
Peripheral2
- Peripheral blood stem cells (PBSC) collected after mobilization with granulocyte colony stimulating factor (G-CSF) contain a large number of CD34-positive progenitors and total cells than bone marrow. (nih.gov)
- Further analysis indicated that peripheral-blood stem cells may reduce the risk of graft failure, whereas bone marrow may reduce the risk of chronic GVHD. (nih.gov)
Diseases1
- This Request for Applications (RFA), Mechanisms of Post Bone Marrow Transplantation Lung Injury, is related to the priority areas of immunization and infectious diseases and cancer. (nih.gov)
Chemotherapy3
- Previous hepatitis and androgen therapy could not be implicated as important causes of hepatic damage but chemotherapy for acute leukaemia and conditioning regimens for bone marrow transplantation appear to be the most important factors in the development of hepatic veno-occlusive disease. (nih.gov)
- Combining chemotherapy with bone marrow transplantation may allow the doctor to give higher doses of chemotherapy drugs and kill more cancer cells. (clinicaltrials.gov)
- The recommended dose is 250 mcg/m2/day administered IV over a 2-hour period beginning two to four hours after bone marrow infusion, and not less than 24 hours after the last dose of chemotherapy or radiotherapy. (wikidoc.org)
Grafts1
- Bone grafts can be used to achieve this. (org.al)
Myocardial1
- According to the myocardial infarction, some articles revealed MSC transplantation has more benefit in increasing left ventricular ejection fraction and systolic wall motion [ 7 ]. (ejao.org)
Engraftment1
- Secondary end points included post-transplantation incidences of neutrophil and platelet engraftment, graft failure, acute and chronic GVHD, relapse, and infections. (nih.gov)
Graft versus2
- Liver dysfunction occurs after bone marrow transplantation but the relative importance of graft versus host disease and other factors, such as infection, radiation, and drugs, has not been clearly established. (nih.gov)
- However, some studies have also shown increased risk of acute and chronic graft-versus-host disease (GVHD), as compared to bone marrow. (nih.gov)
Cord blood1
- Cord blood is rich in stem cells (cells produced in the bone marrow that mature to different types of blood cells), which may prove useful in new sickle cell therapies. (nih.gov)
Transplant8
- A bone marrow transplant is a procedure that replaces a person's faulty bone marrow stem cells. (medlineplus.gov)
- What Is a Bone Marrow Transplant? (medlineplus.gov)
- In February 1988, a bone transplant recipient was diagnosed with acquired immunodeficiency syndrome (AIDS) after being found positive for antibody to human immunodeficiency virus (HIV) and developing Pneumocystis carinii pneumonia (PCP). (cdc.gov)
- The transplant uses healthy 'matched' bone marrow. (clinicaltrials.gov)
- Systemic fungal infections are a major problem in bone marrow transplant recipients who have prolonged neutropenia or who receive high-dose corticosteroids. (nih.gov)
- Researchers testing the effects of two bone active drugs in heart transplant recipients have found that both reduce the degree of bone loss commonly seen in the first year following transplant surgery. (nih.gov)
- Transplant recipients are at high risk for osteoporosis, a skeletal disorder marked by reduced bone strength and fractures, because of the drugs they must take to prevent the body's rejection of the transplanted organ. (nih.gov)
- It is hoped that this will bring more attention to post-transplant bone loss and its prevention. (nih.gov)
19962
- modern free Bone Marrow Transplantation (Vademecum) 1996, Gopher A, Galili E, Hershkovitz I. Musculoskeletal book boas in big sources and joint sections in the Levant: the Quaternary subsistence. (ferienwohnung-hdneckar.de)
- temporal photos free Bone Marrow Transplantation (Vademecum) 1996 for their salvation illegal certificate sex females, but we come consistently that you can improve compensate at a magisterial political g. threatening through a block of books can do a original ride, but when you use our scans on your browser you will have the best Unemployment to revel jS from reply human website content! (ferienwohnung-hdneckar.de)
Donors1
- Allografts are taken from donors or cadavers and they serve as alternatives to autograft in bone reconstruction. (org.al)
Liver1
- Previous reports have identified transmission of HIV through transplantation of kidney, liver, heart, pancreas (1-3), possibly by skin (4), and by artificial insemination (5), but none of these infected recipients have been reported as having developed AIDS. (cdc.gov)
Systemic1
- This study investigated the putative immunemodulatory effects in neuroinflammation of systemic transplantation of MSC into APP/PS1 transgenic mice. (nih.gov)
Complications2
- Because the cell therapy uses a patient's own cells, it negates the risks or complications associated with other treatment options such as rejection linked to transplantation," Boon added. (medindia.net)
- Autogenous bone is generally used as an optimal graft because it integrates faster and with fewer complications. (org.al)
Procedure2
Tumors2
Deficiency1
- Based on research that describes Alexander's disease as a leukodystrophy which may result from an unidentified enzyme deficiency, we attempted marrow transplantation to reverse or arrest the patient's neurological deterioration. (northwestern.edu)
Interventions1
- The trial was difficult to conduct and monitor because of the serious medical conditions involved and the lack of control over the many drugs and interventions related to the transplantation. (nih.gov)
Survival1
- Alanine transaminase was significantly higher in non-survivors and appeared to predict survival early after transplantation. (nih.gov)
Researchers1
- Researchers say the chromosomal shattering probably took place in a cell in the bone marrow. (nih.gov)
Allograft2
- In July 1986, 20 months after receiving the bone allograft, the recipient was evaluated again when she complained of enlarged axillary lymph nodes that she had found during a breast self-examination. (cdc.gov)
- Allograft Transplantation and Reconstruction of Bones after Malignant Tumor Resections. (org.al)
Tissue2
- Bone marrow is the spongy tissue inside some of your bones, such as your hip and thigh bones. (medlineplus.gov)
- The standard in bone grafting consists of tissue harvested from the patient, autograft, usually from the iliac crest or distal femur and tibia. (org.al)
Biological1
- After resection of a large piece of bone, limb reconstruction (when is necessary) can be easily achieved with mechanical reconstruction with metallic prosthesis, or biological reconstruction with bone. (org.al)
Treatment3
- Ex vivo spermine dialdehyde treatment prevents lethal GVHD in a murine bone marrow transplantation model. (duke.edu)
- No significant difference in either bone loss or fracture rate was found between the two treatment groups, and both drug groups showed reduced bone loss compared to the reference group. (nih.gov)
- Recently, transplantation of stem cells has emerged as a promising therapeutic option for the treatment of intractable hearing loss [ 5 ]. (ejao.org)
Cells4
- This destroys the faulty stem cells in your bone marrow. (medlineplus.gov)
- In some cases, you can donate your own bone marrow stem cells in advance. (medlineplus.gov)
- A new method to repair a damaged heart with stem cells offers immense promise and British scientists look forward to the day when transplantation surgeries may not be necessary. (medindia.net)
- The drug alendronate, however, which reduces the activity of cells that cause bone loss, was judged to be more clinically useful than calcitriol, a synthetic substance similar to vitamin D, which helps regulate calcium metabolism in the body. (nih.gov)